HER2 pozitif erken meme kanseri bulunan hastaların antikor-ilaç konjugatı trastuzumab emtansin (T-DM1) ile tedavisine yönelik tedavi yöntemleri ortaya koyulmaktadır.
This record is compiled from official TPMK patent bulletins and is provided for information. The abstract text is as published, in Turkish. The current legal status (opposition, assignment, invalidation) requires a full register review. Ask our experts for a comprehensive patent search.